Core Viewpoint - Minsheng Health (301507) announced that the acquisition of Zhongke Jiayi has effectively driven business growth through brand synergy and influence [1] Group 1: Business Growth and Partnerships - Zhongke Jiayi has established cooperative relationships with leading domestic health food OEMs and milk powder companies, leveraging the brand influence and customer channel advantages of the listed company [1] - The business performance of Zhongke Jiayi aligns with expectations as it continues to deepen strain research and industrial applications [1] Group 2: Future Projects and Opportunities - The "Armor Probiotic Intelligent Manufacturing Upgrade Project" was officially launched by Zhongke Jiayi, expected to bring opportunities in terms of products, costs, efficiency, and market by the end of September 2025 [1] - The company is actively expanding into cutting-edge fields such as weight management, gut-brain axis, and metabolic health [1]

南财智讯11月13日电，民生健康在投资者关系活动中表示，收购中科嘉亿后，借助上市公司的品牌影响 力和客户渠道优势，中科嘉亿已与国内头部保健食品代工企业、乳粉企业等大客户逐步建立合作关系， 业务实现有效增长。2025年9月底，中科嘉亿"盔甲益生菌智造升级项目"已正式启动，新产线将在产 品、成本、效率和市场方面为公司未来发展带来积极影响。公司持续深化菌株研发与产业应用，积极拓 展体重管理、肠脑轴、代谢健康等前沿领域，整体业务表现符合预期。 ...